V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003894 | 300002724 | 1.64 | 68.6 | Neo-adjuvant (N) | 2016-08-14 | 2016-08-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300017240 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003895 | 300002724 | 1.61 | 82 | Adjuvant (A) | 2013-12-06 | 2013-12-18 | Cisplatin +Fluorouracil (3 wk) | N | N | 300017240 | CISPLATIN + FLUOROURACIL |
| 300003896 | 300002725 | null | 49.6 | Neo-adjuvant (N) | null | 2013-09-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300017245 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003897 | 300002725 | 1.58 | 57.2 | null | 2014-12-07 | 2014-12-25 | Cetuximab 7 day (>Cycle 2) | N | N | 300017245 | CETUXIMAB |
| 300003898 | 300002726 | 1.56 | 73.2 | Curative (C) | 2015-12-01 | 2015-12-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300017256 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003899 | 300002727 | null | null | Neo-adjuvant (N) | 2016-06-27 | 2016-07-02 | CARBOPLATIN + PACLITAXEL | N | N | 300017257 | CARBOPLATIN + PACLITAXEL |
| 300003900 | 300002728 | 1.81 | null | Neo-adjuvant (N) | 2013-03-15 | 2013-03-15 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300017262 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003901 | 300002729 | 1.73 | 77.9 | Curative (C) | 2015-03-24 | 2015-03-31 | CETUXIMAB | N | N | 300017268 | CETUXIMAB |
| 300003902 | 300002729 | 1.57 | 77.9 | Neo-adjuvant (N) | 2014-03-27 | 2014-03-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017268 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003907 | 300008206 | 1.58 | 89 | Adjuvant (A) | 2014-12-14 | 2014-12-29 | CETUXIMAB + RT | N | Y | 300017279 | CETUXIMAB + RT |
| 300003908 | 300002731 | 1.69 | 54.5 | Neo-adjuvant (N) | 2017-10-01 | 2017-10-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 300017280 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003909 | 300002732 | 1.6 | 52 | Curative (C) | 2017-07-23 | 2017-07-23 | Capecitabine | Y | null | 300017283 | CAPECITABINE |
| 300003910 | 300002733 | 1.64 | 73.4 | Neo-adjuvant (N) | 2016-09-18 | 2016-09-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017287 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003911 | 300002733 | 1.8 | null | Palliative (P) | null | 2013-08-23 | CISPLATIN + FLUOROURACIL | N | N | 300017287 | CISPLATIN + FLUOROURACIL |
| 300003914 | 300002735 | null | 64.55 | Neo-adjuvant (N) | 2015-05-15 | 2015-06-05 | Capecitabine | N | N | 300017296 | CAPECITABINE |
| 300003916 | 300002737 | 1.57 | 74.2 | Curative (C) | 2014-03-08 | 2014-03-12 | CISPLATIN + FLUOROURACIL | 02 | N | 300017300 | CISPLATIN + FLUOROURACIL |
| 300003917 | 300002738 | 0 | 108.5 | Not known (9) | 2013-05-27 | 2013-06-24 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017305 | CISPLATIN + FLUOROURACIL |
| 300003918 | 300002739 | 1.73 | 75 | Neo-adjuvant (N) | 2013-04-13 | 2013-04-20 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017306 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003919 | 300002740 | 1.58 | null | Neo-adjuvant (N) | 2017-08-25 | 2017-08-25 | Cisplatin +Fluorouracil (3 wk) | null | null | 300017307 | CISPLATIN + FLUOROURACIL |
| 300003920 | 300002740 | 1.67 | 81.4 | Curative (C) | 2013-04-27 | 2013-04-29 | Cetuximab 7 day (Cycle 1) | N | null | 300017307 | CETUXIMAB |
| 300003921 | 300002741 | 1.54 | 108 | Not known (9) | 2013-11-15 | 2013-12-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300017312 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003922 | 300002742 | 1.64 | 72 | Disease modification (D) | 2015-06-10 | 2015-06-11 | Capecitabine | Y | N | 300017316 | CAPECITABINE |
| 300003923 | 300002743 | 1.58 | 60.3 | 3 | 2014-05-21 | 2014-06-14 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017326 | CISPLATIN + FLUOROURACIL |
| 300003924 | 300002743 | 1.62 | 77 | Palliative (P) | 2015-11-11 | 2015-12-02 | Trial Unspecified | N | Y | 300017326 | TRIAL |
| 300003925 | 300002743 | null | 82.9 | Adjuvant (A) | 2015-08-19 | 2015-08-24 | Capecitabine | N | N | 300017326 | CAPECITABINE |
| 300003926 | 300002743 | 1.6 | 50.6 | Curative (C) | 2014-06-05 | 2014-06-05 | CETUXIMAB + RT | Y | Y | 300017326 | CETUXIMAB + RT |
| 300003927 | 300008207 | 1.59 | 87 | Neo-adjuvant (N) | null | 2015-12-01 | Cisplatin +Fluorouracil (3 wk) | null | null | 300017340 | CISPLATIN + FLUOROURACIL |
| 300003928 | 300008207 | 1.65 | 99.4 | Curative (C) | null | 2014-01-29 | CETUXIMAB + RT | null | null | 300017340 | CETUXIMAB + RT |
| 300003929 | 300002744 | 1.58 | 83.2 | Curative (C) | 2013-02-02 | 2013-02-25 | CETUXIMAB + RT | Y | Y | 300017351 | CETUXIMAB + RT |
| 300003930 | 300002745 | 1.49 | 42.6 | Adjuvant (A) | 2013-08-29 | 2013-08-31 | Capecitabine | Y | N | 300017353 | CAPECITABINE |
| 300003931 | 300006030 | 2 | 44.5 | Palliative (P) | 2013-12-19 | 2013-12-31 | CETUXIMAB | Y | Y | 300017356 | CETUXIMAB |
| 300003932 | 300002746 | 1.71 | 72.4 | null | 2014-07-02 | 2014-07-23 | Cetuximab 7 day (Cycle 1) | N | Y | 300017359 | CETUXIMAB |
| 300003933 | 300002747 | 1.61 | null | Palliative (P) | 2015-12-22 | 2015-12-28 | Trial Unspecified | 02 | N | 300017362 | TRIAL |
| 300003934 | 300002748 | 1.62 | 49.6 | Curative (C) | 2014-12-21 | 2014-12-27 | Cetuximab + Radiotherapy Load | null | Y | 300017365 | CETUXIMAB + RT |
| 300003936 | 300002750 | 1.69 | 88 | Palliative (P) | 2014-02-22 | 2014-02-22 | Trial Unspecified | Y | N | 300017374 | TRIAL |
| 300003937 | 300002751 | null | 92.9 | Neo-adjuvant (N) | 2016-08-15 | 2016-08-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017378 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003940 | 300002753 | null | 81.5 | null | 2015-06-04 | 2015-06-14 | CETUXIMAB + RT | 02 | null | 300017385 | CETUXIMAB + RT |
| 300003941 | 300002754 | 1.64 | 44.5 | Adjuvant (A) | 2013-04-07 | 2013-04-07 | CISPLATIN + FLUOROURACIL | Y | N | 300017388 | CISPLATIN + FLUOROURACIL |
| 300003942 | 300002754 | 1.76 | 77.8 | Neo-adjuvant (N) | 2014-11-28 | 2014-11-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017388 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003943 | 300002755 | 1.76 | 61.8 | Neo-adjuvant (N) | 2017-11-02 | 2017-11-03 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300017397 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003944 | 300002755 | 1.67 | 88.1 | Curative (C) | 2015-03-28 | 2015-03-29 | CETUXIMAB + RT | N | Y | 300017397 | CETUXIMAB + RT |
| 300003945 | 300002756 | 1.63 | 77.2 | Palliative (P) | 2014-06-13 | 2014-06-16 | Capecitabine | 02 | null | 300017402 | CAPECITABINE |
| 300003946 | 300002757 | 1.65 | 77.2 | Curative (C) | 2017-12-24 | 2017-12-26 | CISPLATIN + FLUOROURACIL | 02 | null | 300017403 | CISPLATIN + FLUOROURACIL |
| 300003947 | 300002758 | 1.45 | 92.5 | Adjuvant (A) | 2015-03-02 | 2015-03-23 | Capecitabine | 02 | N | 300017406 | CAPECITABINE |
| 300003948 | 300002759 | 1.71 | 79.95 | Neo-adjuvant (N) | 2015-04-10 | 2015-04-19 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017411 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003949 | 300002760 | 1.75 | 92 | Neo-adjuvant (N) | 2013-10-06 | 2013-10-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017414 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003950 | 300002761 | 1.63 | 78.4 | Palliative (P) | 2013-05-23 | 2013-05-30 | CISPLATIN + FLUOROURACIL | N | N | 300017416 | CISPLATIN + FLUOROURACIL |
| 300003951 | 300002762 | 1.77 | null | Neo-adjuvant (N) | 2014-10-12 | 2014-10-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300017426 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003952 | 300002763 | 1.71 | 77 | Curative (C) | 2013-09-13 | 2013-09-14 | CETUXIMAB + RT | 1 | Y | 300017430 | CETUXIMAB + RT |
| 300003953 | 300002764 | 1.69 | 54.3 | Adjuvant (A) | 2018-08-19 | 2018-08-27 | Capecitabine | 02 | N | 300017431 | CAPECITABINE |